4d Molecular Therapeutics In shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.8M | 664k | 8.69 |
| 2025-06-30 | $2.4M | 649k | 3.71 |
| 2025-03-31 | $2.1M | 651k | 3.23 |
| 2024-12-31 | $3.6M | 654k | 5.57 |
| 2024-09-30 | $17M | 1.5M | 10.81 |
| 2024-06-30 | $9.6M | 456k | 20.99 |
| 2024-03-31 | $14M | 431k | 31.86 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management